ArticleCureus2024
Cancer Patients' Views on Ultrahypofractionated Radiotherapy: A Questionnaire-Based Survey.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionUltrahypofractionated (UHF) radiotherapy provides several treatment schedules, including five fractions per week (5/5-UHF), three fractions per week (3/5-UHF), and one fraction per week (1/5-UHF). This study aimed to assess patient preferences for these UHF radiotherapy schedules and offer insights to support patient-centered radiotherapy.
methodsA questionnaire survey was conducted among cancer patients who had received at least 10 fractions of definitive or palliative radiotherapy, delivered on consecutive weekdays at our institution. The survey was administered during the final week of treatment and included four questions regarding the patients' living conditions and seven questions about their perceptions of radiotherapy, including preferences for UHF radiotherapy schedules.
resultsBetween April and July 2023, 71 eligible patients completed the questionnaire. The mean age was 65.2 years; 48 patients (68%) were male, and 36 patients (51%) were inpatients. Thirty-one patients (44%) traveled more than one hour to the hospital, and 34 patients (47%) reported stress from daily hospital visits for radiotherapy. In response to the question, "If you were to receive 5-fraction radiotherapy, would you choose 5/5-UHF, 3/5-UHF, or 1/5-UHF?" 64 patients responded. Among these, 27 (42%) chose 5/5-UHF, 19 (30%) chose 3/5-UHF, and 18 (28%) chose 1/5-UHF. Regarding the question, "Which is more important: a shorter treatment period with the same fractionation or reduced fractionation with the same treatment period?" 31 patients (48%) prioritized shorter treatment periods, while 12 (19%) preferred reduced fractionation. Although approximately half of the patients expressed distress from consecutive days of radiotherapy, the shortest treatment period was generally preferred, even if it involved consecutive sessions. The 1/5-UHF radiotherapy schedule was particularly popular among younger male patients, those with longer travel times, and those working full-time.
conclusionThese findings suggest that tailoring radiotherapy schedules to patients' social circumstances may enhance overall satisfaction with treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.